FDA product code QNL: Medium-Term Adjunctive Predictive Cardiovascular Indicator
QNL is the FDA product code for medium-term adjunctive predictive cardiovascular indicator. It is a Class II device, regulated under 21 CFR 870.2210 and reviewed by the Cardiovascular panel. FDA has cleared 6 510(k) submissions under QNL, 5 in the last five years, from 5 different applicants. The average 510(k) review took 208 days (median 235); 223 days on average over the last three years.
Definition
The adjunctive predictive cardiovascular indicator is a prescription device that uses software algorithms to analyze cardiovascular vital signs and predict future cardiovascular status or events within a defined medium-term period. This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.
Classification
| Field | Value |
|---|---|
| Device name | Medium-Term Adjunctive Predictive Cardiovascular Indicator |
| Device class | Class II |
| Regulation | 21 CFR 870.2210 |
| Review panel | CV — Cardiovascular |
| Medical specialty | Cardiovascular |
| Premarket route | 510(k) |
510(k) clearances per year for QNL
| Year | Clearances | Avg. review days |
|---|---|---|
| 2021 | 1 | 297 |
| 2023 | 2 | 158 |
| 2024 | 2 | 187 |
| 2026 | 1 | 259 |
Compare with all 510(k) review times · Search every QNL clearance
Top QNL applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Clew Medical , Ltd. | 2 | 2024-01-13 |
| Epic Systems Corporation | 1 | 2026-09-18 |
| Agilemd, Inc. | 1 | 2024-06-21 |
| Implicity, Inc. | 1 | 2023-10-25 |
| Edwards Lifesciences, LLC | 1 | 2023-07-26 |
Most recent QNL clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K260008 | Epic Systems Corporation | Deterioration Index Version 2 | 2026-09-18 | 259 |
| K233253 | Agilemd, Inc. | eCARTv5 Clinical Deterioration Suite (eCART) | 2024-06-21 | 267 |
| K233216 | Clew Medical , Ltd. | CLEWICU System | 2024-01-13 | 107 |
| K230842 | Implicity, Inc. | SignalHF (IM008) | 2023-10-25 | 211 |
| K231038 | Edwards Lifesciences, LLC | Global Hypoperfusion Index (GHI) Algorithm | 2023-07-26 | 105 |
Recalls for QNL devices
FDA recall records list no recalls for product code QNL.
Frequently asked questions
What is FDA product code QNL?
QNL is the FDA product code for medium-term adjunctive predictive cardiovascular indicator. It is a Class II device, regulated under 21 CFR 870.2210 and reviewed by the Cardiovascular panel.
What device class is QNL?
Class II, regulation 21 CFR 870.2210. Typical premarket route: 510(k).
How long does a 510(k) take for product code QNL?
Across 6 cleared submissions the average was 208 days from receipt to decision (median 235).
Which companies have the most QNL clearances?
Clew Medical , Ltd. (2); Epic Systems Corporation (1); Agilemd, Inc. (1); Implicity, Inc. (1); Edwards Lifesciences, LLC (1).
Next steps
- Run an FDA pathway report with predicate devices for product code QNL
- Run a recall and safety report across every QNL manufacturer
- Watch product code QNL for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times